Bruce N. Jacobs, Chief Financial Officer at Kymera Therapeutics, Inc. (KYMR), sold 38,900 shares at $45.75 ($1.7M) on 2021-03-03, disclosed to the SEC on 2021-03-05.
Open-market sale of $1.7M KYMR by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $44.12 | 6,881 | $304K | 17.4% |
| 2 | $44.12 | 6,881 | $304K | 17.4% |
| 3 | $45.07 | 12,019 | $542K | 31.1% |
| 4 | $45.07 | 12,019 | $542K | 31.1% |
| 5 | $45.75 | 1,100 | $50K | 2.9% |
| Total | $44.75 avg | 38,900 |
| $1.7M |
| 100% |
| Filing → |
| KYMR | SELL | 2025-09-17 | $4.0M | — | Filing → |
| KYMR | SELL | 2025-03-03 | $389K | — | Filing → |
| KYMR | SELL | 2024-03-04 | $318K | — | Filing → |